Select for export GMP-compliant radiosynthesis of [18F]altanserin and human plasma metabolite studies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.apradiso.2008.12.007 PubMed 19162492 Copy citation Copy BibTeX Unknown journal 2008-12-23 Hasler F, Kuznetsova OF, Krasikova RN, Cservenyak T, Quednow BB, Vollenweider FX Europe PMC Published psilocybin PharmacologyReceptor Pharmacology Clinical Trial More
Select for export Serotonin research: contributions to understanding psychoses. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.tips.2008.06.006 PubMed 19086254 Copy citation Copy BibTeX Unknown journal 2008-08-31 Geyer MA, Vollenweider FX. Europe PMC Published psilocybin Brain ImagingReceptor PharmacologyConsciousness Review Article More
Select for export Effects of the hallucinogenic 5-HT2A agonist psilocybin on object completion in humans No abstract availability was recorded for this entry. Details DOI 10.1016/j.ijpsycho.2008.05.397 Copy citation Copy BibTeX International Journal of Psychophysiology 2008-07-16 F.X. Vollenweider, Daniel Hell, Michael Kometer OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-007-0930-9 PubMed 17874073 Copy citation Copy BibTeX Psychopharmacology 2007-09-13 Carter OL, Hasler F, Pettigrew JD, Wallis GM, Liu GB, Vollenweider FX. Europe PMC Published psilocybin Receptor Pharmacology Other More
Select for export The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/sj.npp.1301324 PubMed 17299516 Copy citation Copy BibTeX Neuropsychopharmacology 2007-02-13 Vollenweider FX, Csomor PA, Knappe B, Geyer MA, Quednow BB. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessAnimal Study Clinical Trial More
Select for export Effects of psilocybin on time perception and temporal control of behaviour in humans. Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Queensland's institutional digital repository (The University of Queensland) 2006-05-18 Wittmann M, Carter O, Hasler F, Cahn BR, Grimberg U, Spring P Europe PMC Published psilocybin Receptor PharmacologyConsciousnessDrug Interactions Other More
Select for export Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1162/089892905774597191 PubMed 16269092 Copy citation Copy BibTeX Journal of Cognitive Neuroscience 2005-09-30 Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyDrug Interactions Other More
Select for export Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/sj.npp.1300621 PubMed 15688092 Copy citation Copy BibTeX Unknown journal 2005-05-31 Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D Europe PMC Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Psilocybin impairs high-level but not low-level motion perception. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/00001756-200408260-00023 PubMed 15305143 Copy citation Copy BibTeX Unknown journal 2004-07-31 Carter OL, Pettigrew JD, Burr DC, Alais D, Hasler F, Vollenweider FX. Europe PMC Published psilocybin Receptor Pharmacology Other More
Select for export The Effects of he Hallucinogenic Serotonin 1A/2A Agonist, Psilocybin, on Binocular Rivalry and Visual Contrast Detection Thresholds No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Queensland's institutional digital repository (The University of Queensland) 2003-12-31 O. Carter, David Alais, David C. Burr, Felix Hasler, G. Liu, Guy Wallis OpenAlex Published psilocybin Receptor Pharmacology Other More
Select for export Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-003-1640-6 PubMed 14615876 Copy citation Copy BibTeX Unknown journal 2003-11-12 Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX. Europe PMC Published psilocybin AnxietyReceptor PharmacologyConsciousness Other More
Select for export P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(03)92355-8 Copy citation Copy BibTeX European Neuropsychopharmacology 2003-09-30 Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider OpenAlex Published psilocybin DepressionAddictionPharmacology Other More
Select for export A double-blind, placebo controlled study of the effect of the hallucinogenic 5-HT1A&2A agonist psilocybin on binocular rivalry rate and rhythmicity No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Social Neuroscience 2002-12-31 O. Carter, Shaun P. Collin, Felix Hasler, George Liu, Franz X. Vollenweider, John D. Pettigrew OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/sj.npp.1300005 PubMed 12496954 Copy citation Copy BibTeX Unknown journal 2002-12-31 Umbricht D, Vollenweider FX, Schmid L, Grübel C, Skrabo A, Huber T Europe PMC Published psilocybin PharmacologyReceptor PharmacologyHealthy Volunteers Other More
Select for export Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0006-3223(01)01242-2 PubMed 11904134 Copy citation Copy BibTeX Unknown journal 2002-02-28 Umbricht D, Koller R, Vollenweider FX, Schmid L. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessHealthy Volunteers Other More
Select for export Brain mechanisms of hallucinogens and entactogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31887/dcns.2001.3.4/fxvollenweider PubMed 22033605 Copy citation Copy BibTeX Unknown journal 2001-11-30 Vollenweider FX. Europe PMC Published psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Review Article More
Select for export A systems model of altered consciousness: integrating natural and drug-induced psychoses. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0361-9230(01)00646-3 PubMed 11750795 Copy citation Copy BibTeX Unknown journal 2001-10-31 Vollenweider FX, Geyer MA. Europe PMC Published psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Other More
Select for export 177. NMDA and 5-HT2A receptor dysfunction in working memory deficits in schizophrenia No abstract availability was recorded for this entry. Details DOI 10.1016/s0006-3223(00)00439-x Copy citation Copy BibTeX Biological Psychiatry 2000-03-31 Daniel Umbricht, F.X. Vollenweider, L. Schmid, R. Koller OpenAlex Published psilocybin PharmacologyReceptor Pharmacology Other More
Select for export 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0893-133x(98)00108-0 PubMed 10192823 Copy citation Copy BibTeX Unknown journal 1999-04-30 Vollenweider FX, Vontobel P, Hell D, Leenders KL. Europe PMC Published psilocybin Receptor PharmacologyHealthy VolunteersDrug Interactions Other More
Select for export Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1097/00001756-199812010-00024 PubMed 9875725 Copy citation Copy BibTeX Unknown journal 1998-11-30 Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D. Europe PMC Published psilocybin Receptor Pharmacology Other More
